JDRF Research Updates – As Requested

On June 27, 2012, I attended a JDRF Research Update meeting.  I sent out a message on Facebook and Twitter about being there and that I was enjoying the updates.  There were a handful of people who asked me to share what I was learning.  So here we go!

JDRF Research has been split into three focuses:

  1. JDRF Cure Research – halting the autoimmune process and restoring normal insulin production.
  2. JDRF Treat Research – Developing new devices and therapies that optimize blood sugar control and treat or prevent T1D complications.
  3. JDRF Prevent Research – Preventing the autoimmune process from starting or stopping it before the onset of insulin dependence.

(there has been a lot of emotional energy around JDRF splitting focuses (ie, not spending 100% of their energy on curing T1D).  That subject is not in my scope for this particular post. )

All of this information has been taken, verbatim (except for my typo’s), from the handout given at the event titled “JDRF Research – Top 10 Advances of FY2012”


 

 

 

Targeted Immune Rebalancing Therapy Starts Clinical study

A JDRF-supported study launched at the University of California at San Francisco is enrolling patients with recent onset T1D to test a therapy for rebalancing their immune system.  A patient’s “T-regs” (cells that regulate the immune system) will be grown in the lab then re-infused to the patient.  The hope is that these added T-regs will halt the destructive “killer” T-effector cells that attack beta cells.  This milestone represents the first human test of such a T1D therapy.  (Learn more at clinicaltrials.gov (Scott’s note – that is a huge website, and I couldn’t locate the specific study))

An Explosion of Newly Discovered Beta Cell Regeneration Pathways

Four JDRF-supported researchers (from Pittsburgh, Stanford, Zurich and Jerusalem) have identified unique and new pathways that control beta cell proliferation and might be activated with novel drug therapies.  Some have even been turned on with prototype drugs in animal studies; others are at an earlier research stage.  The concept of drugs to stimulate beta cell proliferation is becoming a reality.  Drugs exist to promote cell proliferation in other diseases; hopefully one of these newly discovered pathways will yield a T1D drug for beta cell proliferation. (Learn more at jdrf.org/betacell/regeneration)

Invention of Novel Oxygen-Producing Biomaterial for Beta Cell Encapsulation

Implanting encapsulated beta cells in a person with T1D could make them independent of external insulin use, but several hurdles exist.  The key challenges are keeping the cells alive with oxygen and nutrients and protecting them from further immune attack.  JDRF-supported researchers at the University of Miami invented a new type of biomaterial that produces oxygen to sustain beta cells immediately after implantation.  This novel biomaterial should accelerate beta cell encapsulation progress by overcoming a key technical hurdle. (Learn more at jdrf.org/betacell/replacement)

Blood Test for Beta Cell Death Discovered

Current tests to detect and measure T1D are crude and cannot directly measure beta cell death.  JDRF-supported researchers at Yale University discovered a new blood test that measures the release of beta cell DNA after they die.  In mice, it could distinguish between mice with and without T1D.  Better tests will allow earlier T1D detection and treatment by signalling the first signs of the disease process at the beta cell level.  Such tests could also speed clinical studies of promising new therapies by allowing more rapid assessments of the effect of a new therapy on beta cell survival.  (Learn more at jdrf.org/CureT1D)


 

 

FDA Issues Draft AP System Guidance as a Result of JDRF-Led Effort

JDRF-led grassroots advocacy including support from professional clinical associations helped drive FDA to produce draft guidance for development of artificial pancreas systems.  While JDRF provided FDA suggestions to improve the draft guidance, the expectations for clinical studies and approval of such systems are reasonable.  JDRF is working closely with the FDA as the draft guidance is finalized.  This guidance will speed JDRF’s APP clinical studies, especially outpatient studies, by informing researchers and companies of FDA’s recommendations. (Learn more at jdrf.org/app/plan)

JDRF APP Consortium Conducts the First Real World Test of an Artificial Pancreas System

Previously, all APP human testing had been done in a controlled hospital setting to be certain there were no significant safety concerns and because of the lack of regulatory guidance for such systems.  The JDRF-supported study of a handheld device for controlling insulin delivery performed well in controlling non-mealtime insulin requirements.  JDRF-supported real world testing in the US has recently begun, coordinated by the University of Virginia.  Real world testing of AP systems moves them a big step closer to delivering them to patients. (Learn more at jdrf.org/app/plan)

JDRF Challenged the World to Invent Glucose Responsive Insulin Products for T1D

A glucose responsive insulin (GRI) would release insulin in the body only when needed and might be taken only once daily or once weekly.  JDRF issued a $100,000 Challenge Prize to anyone who could develop a novel way to achieve a GRI product.  JDRF will announce the Challenge Prize winners in summer 2012.  JDRF is seeking creative solutions for novel T1D products from anywhere around the world; expanding the pool of talent focused on discovering and developing new T1D products.  While still at an early stage, such a GRI product could transform T1D management.  (Learn more at jdrf.org/gct)

Novel Markers of Kidney Disease Risk in T1D Discovered

Kidney disease is a serious complication of T1D and is very difficult to predict in people with T1D, since not everyone with T1D develops it.  JDRF-supported researchers at the Joslin Diabetes Center in Boston have discovered proteins in the blood that are strongly associated with kidney disease risk in people with T1D.  This finding could form the basis of a simple blood test for kidney disease risk in people with T1D.  The earlier identification of someone with T1D at risk for kidney disease will allow earlier treatment and better management of this serious T1D complication.  (Learn more at jdrf.org/complications/prevention)


 

 

Focused a Novel Vaccine Technology on T1D Prevention

Targeted T1D Vaccines are ones focused on the specific beta cell components to which the immune system mistakenly reacts.  A vaccine focused on these beta cell components could stop the autoimmune process before a person becomes insulin dependent.  JDRF is supporting this unique nanoparticle-based vaccine technology by partnering with Selecta (a Massachusetts based company) to ensure they focus their efforts on T1D, something not previously a priority for them.  Vaccine research is one of the most promising approaches to prevent or halt the beta cell-specific autoimmunity in T1D.  (Learn more at http://jdrf.org/research/prevent/)

Strengthened the Link between Enteroviruses and T1D

Enteroviruses are small viruses often found in a person’s gut.  Previous studies have linked them to T1D but the connection was not clear.  This new JDRF-supported research in Finland has now shown that enteroviruses can become a persistent infection in the gut lining of people with T1D and showed they can cause related inflammation, potentially a trigger for the T1D autoimmune response.  Development of a vaccine or anti-viral agents that target these enteroviruses may be a possible T1D prevention strategy. (Learn more at http://jdrf.org/research/prevent/)


And that wraps up the official news given at the research update.  Simply reading all of this doesn’t really capture the excitement that was evident in the presenting speakers.  I should also note that if you have questions on any of these updates, you should probably ask your local JDRF group for help.  In this case, I’m just a messenger.

JDRF “Reach And Teach U” Event

Last weekend I attended a JDRF event called “Reach and Teach U” held in Bloomington, MN (one of the Twin Cities nearby suburbs) near the Mall of America.

This was the third annual event, but it was the first I had heard of and attended.  There was no charge (but pre-registration was required).  It was scheduled to go from 8:00 AM – 2:30 PM, with a number of presentations and educational updates.  They even had JDRF KidKamp for children ages 3+ (there was a magician and some other fun activities for the kids while parents and caregivers attended sessions).

There were only a few exhibitor booths there, and in all honesty, it didn’t seem like there was much time to visit them anyway.  Maybe it was just me, but I felt like I didn’t have much opportunity to check out the booths without missing one of the presentations.  I felt very pressed for time.

The opening keynote was incredible.  Dr. Nat Strand, listed as “Amazing Race Winner, Type 1 Diabetic, Optimist” gave an energetic talk about her experiences navigating diabetes and winning (!!) the ‘Amazing Race’ (Season 17) on CBS.  It was really something else.  The adventure took her around the world in 23 days, and she had to pack everything she would need in a single backpack.  She talked about working closely with her CDE who gave her great tips that helped immensely (such as removing some of her pump supplies from the bulky plastic packaging – sacrificing perfect sterility in order to save space).  She said the producers and support staff were very ‘by the book’ and wouldn’t even hold a spare bottle of insulin for her.  Nothing.

The first thing the producers aired containing anything about her diabetes was a clip of her doing a blood test and it coming back at 337 mg/dl.  She talked about how embarrassed she was – with that being her introduction to the world as a person living with diabetes and not being able to show a good number.  But shortly after that episode aired, she started getting all sorts of letters and e-mails thanking her for showing real-life diabetes.  Anybody with diabetes would probably have crazy blood sugars zipping around the world and enduring crazy stressful challenges and events!

Picture of Scott, Leah, and Dr. Nat Strand

Scott, Leah, & Dr. Nat Strand

I got to sit with Leah, who was super excited about listening to Dr. Strand speak.  After her presentation was done, Leah and I went to talk with her.  Leah told Dr. Strand about how she was a big fan of the show, and was diagnosed with type 1 diabetes just before her season (17) started.  Leah  said it was a HUGE boost for her to watch Dr. Strand go out there, battling highs and lows, and doing all of these crazy things.  It was very emotional, and I could tell it was a big deal for Leah to have this opportunity to talk with Dr. Strand and share her story.

There were a few other sessions that were interesting that afternoon, everything from research updates to radical acceptance to diabetes service dogs.  During lunch I was able to help convince my friend Cynthia to start her own blog, which was very exciting to me.  I also ran into Dr. Robert Larson, the incredible pediatric endocrinologist who took care of me and my diabetes for twenty-some years as I was growing up (more to come with him soon!).

A large portion of the lunch time was spent kicking off the 2012 JDRF Walk.  Honestly,  it felt kind of weird.  Like “Oh, THAT’s why they are doing all of this stuff today…”  Or maybe my expectations were just not in the right place.  I think if it is a walk kickoff event, call it a walk kickoff event.

Either way, it was a day well spent, and I would probably do it again.

Diabetes Is Intense – Lisa Finander

Lisa Finander

Lisa Finander (photo courtesy of Anita Jader Photography)

Lisa Finander was the guest speaker at the last ‘Adults With Type One‘ group.  This was the second time I’ve heard Lisa present, and it was every bit as great as I remembered.  She has lived with type 1 diabetes since 1969, which gives her a ton of street cred in my book.

Lisa talked about how things were back then.  Not the typical stories you hear, about testing urine and sharpening needles (she said disposable syringes just hit the scene).  But rather how there wasn’t much training, if any, available.  They were mostly on their own and had to just “figure it out.”

She said that diabetes has come a long way since then, which is great – but in some ways, many things are still the same, and many beliefs are still the same, which is disappointing.

All of a sudden, your focus changes.  You are no longer just trying to figure out life – now you have all of this extra stuff to learn.  Nobody recognizes that.  Nobody acknowledges that huge focus change.  It’s an incredible disruption in life, and nobody talks about coping with it.

“Diabetes is an intense way to live.  It’s intense.” said Lisa,  “There are days when it absorbs all of who I am.”

That stuck with me – because she is right.  Diabetes is intense.  But we get so practiced, and do so many things over and over again, we lose sight of just how intense everything in our day really is.

It’s not until the end of the day when the exhaustion washes over me and is replaced by a fear of what may happen while I sleep.  And because that process happens every single day, I find that I’m a bit numb to it…

She told the story of an endocrinologist who was surprised to see a patients entire body relax once he delivered the results of an improved A1C test.  He didn’t even realize how stressful it is for people to come in and see him — that’s something we think of as a no-brainer!

Lisa talked about finding what she calls “healthy familiars”.  These are things that foster your well being, that foster your health, and that you can reach for when you’re feeling stressed and/or overwhelmed.

One of her favorites is a cup of green tea and a shawl.  It helps her find a different feeling when she’s feeling bad.  Rather than reaching for stuff that makes her feel guilty, she has, very purposefully, created these things that both comfort her and support her well being.  I love that.  But I think I’ll need to find something other than Diet Coke.

“We are not alone,” she says, “it often feels that way, but we’re not alone.  We’re not flawed, we’re not less than.  Diabetes may mean we need extra care and extra love, but I don’t think that is asking too much.”

Lisa ended her fantastic talk by saying “it’s not a bad thing to give ourselves love and care.”

Lisa is the author of a fun Disney book called ‘Disneystrology‘.  It is not directly diabetes related, but she says it was the process of writing and assembling this book that really helped her find herself in regards to her life with diabetes.

It was a pleasure listening to Lisa present again, and if you are ever given the chance to hear her present, I encourage you to make it happen.

If you’d like information about any of the local support groups I attend here in the Twin Cities metro area, let me know and I’ll fill you in.

JDRF – Promise To Remember Me

The JDRF volunteers around the Minneapolis area are very active.  I’m lucky to live here so I can participate in some of the great things they are doing.

My trip to Capitol Hill early in the year helped me get to know some of the people in the Grassroots Advocacy team, and since then we’ve worked to keep the relationships going and the advocacy efforts moving.

Group shot of us with Erik PaulsenMonday is a great example.  A group of about 12-13 of us met with our district congressman, Erik Paulsen.

This time of year the JDRF Promise Campaign swings into full steam.  The idea behind this is to get local families and those living with type 1 diabetes to tell their story to their local representative, and ask them to “remember me” when they are on Capitol Hill making decisions that will affect us.

The JDRF Advocacy group does a great job of organizing “asks”.  That is, what are we to ask for while we are there?  This provides a consistent set of high level pushes coming from as many of the congressmen and representatives that we can get on board.  We did our best to intermingle these asks into our personal stories, and the truth is that they actually fit very well there.

We spent about a half-hour visiting with Congressman Paulsen, and it was clear to me that he was interested in doing whatever he could to help.  He gave each of us his undivided attention, and asked some great questions.

We talked about the continued support of funding to the NIH and FDA, and lobbying the FDA to keep things moving with the artificial pancreas.   We talked about concerns over healthcare, and how many of the parents were terrified about satisfactory coverage.  We talked about the financial burdens of life with type 1 diabetes, and the scary instances of those we’ve lost.

My impressions when it was all said and done?  He gets it.  He gets it and will do all that he can to help (within the political and logistical limits he’s bound to).

The world is not going to change as a result of one meeting, a few meetings, or even a hundred meetings.  But as we continue to push for better, and develop relationships where possible, they will remember us as they are on The Hill battling out budget cuts and voting on proposals.  That is why “Promise To Remember Me” is important.

As a normal, average, everyday Scott, living life with type 1 diabetes – was it much to ask for me to volunteer a couple hours of my afternoon?  Not at all.  As someone who is totally politically ignorant, was it intimidating to do?  Absolutely.  But you know what, it was easy.  It was all about telling my story about life with type 1 diabetes.  That’s it.  One person to another.

Do not be afraid to get involved.  If I can do it, anyone can.

2011 Roche – Growing Potential, Still Vague

Manny pretending Scott's bald head is a crystal ball

Manny trying to read the future in Scott's crystal ball

As hard as he tried, Manny Hernandez could not see what was in the coming days of the 2011 Roche Social Media Summit.

I bet he got pretty close though.  Friends, fun, relationships, the greater good, and the sense that we can influence change.

I personally felt that this, our third summit, was the best yet.   Nurturing relationships is part of what makes these in-person meetings important.  But as a group, it seems that we were better prepared to handle the excitement of seeing each other in person again, and didn’t let that get in the way of  a productive summit.

For the most part, the group was all about figuring out how to make change happen.  I could feel it in the room, and I loved it.  We are starting to trust Roche Diabetes more, thanks to the work Todd and Rob put in through the year, and how they respect us at the summits.   I felt this year was even less about Roche Diabetes, and more about them (Roche) being able to facilitate good things.  Do you see why that is important?  They understand that the way to gain our trust and respect is to show us that they are about the greater good – not just increasing Roche’s bottom line.

And by working towards helping more people with diabetes, they are growing their bottom line.  And that is Ok!  We need companies to make money from diabetes or else we will be abandoned.   Unfortunately, there will always be more help needed than is available, but taking steps to do what they can is important in my opinion.

Advocacy is Education

We are all advocates.  All of us – not just the small sampling of people at the summit.  If you live with diabetes, you are an advocate.  By living your life you are telling a strong story.

So much of advocacy is education.  Us educating people without diabetes.  Organizations educating us about their missions and goals.  All of us educating decision-makers about why diabetes is not Ok.

For the past two summits, Roche has gotten us an audience with some important organizations.  Last year was the ADA and the AADE.  This year was JDRF and the IDF (International Diabetes Federation).  I wrote briefly about my thoughts with them already, and I am thankful to have had the opportunity to be educated.

I was frustrated by our group’s behavior when Isabella Platon, Head of Communication with the IDF, presented.  The group pretty much jumped down her throat for not having better relationships with us.  I call bullshit on that attitude, and ask that WE realize that they are very busy finding ways to keep people from dying because they can’t get their insulin.

We have responsibilities to help them too – advocacy is not a one-way street.  As people who have found a small channel to tell our stories, we need to step up and pro-actively help organizations that need it.  Shame on us for being so full of ourselves that we have ignored kids dying from lack of insulin.  Shame on us.

Still Vague

While I felt the cohesiveness of the group coming together, I also felt a desire to channel the energy towards something great that we weren’t quite able to catch.  We spent a short amount of time brainstorming, and we got close to a lot of great ideas.  But that was about it.   Just close.

I think we might have been trying to force magic, when that’s just not the way it works.  The world has huge, possibly unrealistic, expectations coming from these summits, and I think we all feel a lot of pressure to deliver.  But deliver what exactly?  Proof that we’re not bought and paid for?

I’d like to hear from people more about what they expect to come from these meetings?

I think the relationships we are building are very powerful examples of great things coming from them.  And let’s not forget, not everything that is a result of these relationships is tangible.  What about empowering someone to live their life with diabetes through a story we tell, or experience we share?  That’s something.  At least I hope it is!

Paperwork

Roche Diabetes paid for my travel, meals, and accommodations for the summit.  Roche did not pay for the couple hundred bucks in overdraft fees resulting from the hotel’s hold on my bank card (free travel is never free folks – this stuff costs me money I don’t have).  Roche did not ask any of us to write about anything, even though they knew we would (and we’re totally happy to do so).  Roche did not put any conditions on what we write about or don’t write about.  Todd & Robb, Adam & Jill – thank you all!  Everything was well organized.  Lisa!  We missed you!  Also – big thanks for making DSMA and DSMA Live hugely successful and historic!

 

One of the Minnesota Crews

I love meetups.

I will do almost anything in my power to get to them.  I missed a group meeting on Monday night, which bummed me out a bit, but couldn’t be helped.

Last night was a different story though.  I spent a few hours visiting with Dean, Mike, and MissItaly.  I loved it (as usual).

A picture of Scott, Dean, Mike (with missitaly behind the camera)

Scott, Dean, Mike (with MissItaly behind the camera)

And I didn’t even have to travel out of state for this one!

This little social get-together is one of three groups I attend regularly.  There is one in Woodbury, MN, affiliated with the HealthEast system (you don’t need to be seen there to come, but you have to be diabetic or love one of us…(hi Diane!).  There is another in the Bloomington, MN area, called AWTO (Adults With Type One) that is put together by a couple JDRF volunteers (hi Matt & Becky!).   Then there is this one, which is just a group of us getting together to socialize.

The Woodbury and Bloomington meetings are a tad more formal, usually featuring a speaker and/or topic of discussion (but also plenty of time to socialize).

Please let me know if you’d like more information on any of the meetings.  I go to all of them (when I can), and get a lot of value from each of them.

I’ll even help you get there if you need a ride.

2011 JDRF Government Day Takeaways

Picture of the MN JDRF crew on Capitol Hill

Shelley, Debbie, Scott, Camile, Ann

Did you know there is a whole section of JDRF that deals with Government Relations?  Me either – at least not until this trip.

When I think JDRF, I always think about fundraising and walks, stuff like that.  I didn’t think about people keeping an eye on government stuff.

It makes sense though, if you think about it.  There are many decisions made on Capitol Hill that directly impact us, positively or negatively, in our daily lives with type 1 diabetes.

Partnerships

As I learned more about the many things the JDRF is, and has been, involved in, I was impressed by the scope of their vision.  Beyond government relations, the JDRF is actively involved with the NIH (and many others), together funding a number of important studies.

We listened to a great presentation given by Judith E. Fradkin, M.D., Director of Diabetes, NIDDK, NIH (that’s a mouthful!) and Richard Insel, M.D., Cheif Scientific Officer, JDRF, about some of the active partnerships and how the NIH & JDRF research is making progress at all stages of type 1 diabetes (preventing onset of autoimmunity, stopping active autoimmune attack, preserving beta cells, improving glucose control, restoring beta cell function, and dealing with complications).

If you’re looking for hard data here, numbers and figures, I’m the wrong guy.  But just for kicks I’ll throw out a really complicated phrase from one of the slides:

JDRF and NIH Research: How Does the Microbiome Confer Immunoregulation and Alter T1D Susceptibility?

I have no idea what that means.

I found an old report on the NIH website from back in 2005 and a new video with Dr. Judy Fradkin from the NIH that was taken at this years JDRF Government Day event.   They are totally unrelated to each other, but does show that NIH & JDRF were working closely together back in 2005, and they are still working closely together today.  You can tell from her video, Dr. Fradkin (who still sees patients, by the way) is excited and engaged with us.

Back to advocacy

After spending two days learning about some of what the JDRF is doing, who they are working with, and what the messages for our representatives were, we went out to our representative’s offices to ask for their support.

I got to hang out with the group from Minnesota, and watch them in action.  They were a blast to be with, and once we got into those representative’s offices, they handled their business – on behalf of all of us living with diabetes.

I don’t think us average folk out here appreciate the gravity of some of the things being advocated for.  For example, what do you think will happen if the FDA’s budget is cut?  We already think they are slow, right?  Imagine if they had less people and fewer resources?  Wouldn’t that slow things down even more?

These things all feel so far away from us, and they are, I guess.  But it doesn’t take long for some of these decisions to affect our lives.

They Have NO Clue

We didn’t get to meet with any actual members on The Hill.  We met with aids from different areas of their offices.  While I was very impressed with them in general, most of them didn’t know the first thing about life with diabetes.  It’s terrifying to think about the power of a signature when they are so disconnected from what we deal with on a daily basis.

With that in mind, it is our job to educate them and let them know where we need their support, and how a decision will help or hurt us.

Some People Enjoy Government

I do not enjoy government stuff.  While the atmosphere around all of the old buildings is pretty cool, I found the inside of the two buildings I saw to be very boring and sort of sterile.  If it weren’t for the company of the Minnesota JDRF gals, I wouldn’t have enjoyed it much at all.

But stepping back from the event a bit, this work is necessary.  Critical even.

These politicians are a different breed to me, and it’s weird to watch them be interested in what we have to say – but only because it’s their job.  I think about how many different groups come in each day to pitch their story, and whether any of these people think about us after their work day is over.  Did we make an impression?  Or were we just another group of activists?

Would I Do It Again?

Of the four days I spent in D.C., two of them were a lot of fun, and two of them were a lot of work.

The fun days were listening to the presentations, learning about everything that the JDRF is involved in, and getting to know some of the other volunteers who work so hard for us.

The not-so-fun days were the two days spent on The Hill. They were exhausting, and not much fun at all (except for hanging out with the MN gals). We ran from meeting to meeting to meeting, with lots of waiting in between.

These trips are hard for me, taking time away from my family, not being able to work on stuff that actually helps pay the rent, and dealing with out-of-pocket expenses that, while often reimbursed, still have to come out of the “rent and groceries fund” for a while.

But if I have the pleasure of being invited back again next year, I will enjoy the two days of fun, and proudly sacrifice two days on The Hill to help educate and advocate.

It’s the least I can do.

**Disclosure: JDRF paid for my food, travel, and lodging.  They did not place any expectations or restrictions on my writing about the trip, and have no editorial control of what I write about it.

Thank You, JDRF!

A quick, post-trip vlog post that I recorded last night after getting home from the airport.

I know that I look half asleep already, and I’m probably even slurring my words a little bit… but I wanted to get a quick “thank you” out to the JDRF and everyone else I met these past few days.

More to come after I get caught up on my rest!

2011 JDRF Government Day

Logo for JDRF Government DayI am excited to have received an invitation from the JDRF Grassroots Advocacy group to join them for the 2011 JDRF Government Day event, starting this afternoon in Washington, D.C.

The event actually lasts four days, and is a mix of updates, information, advocacy training, and meeting with representatives from Congress.  Their goals for this event are to grow the JDRF network and to support and advance the broader diabetes community (as Mike Kondratick, Director, JDRF Grassroots Advocacy, recently stated).

This year, they’ve invited some of us from the Diabetes Online Community to join them and share our perspectives on the advocacy needs of the diabetes community and talk about ways we can all work together to achieve them.  Nine of us are volunteering our time and energy to attend this event and see what it’s all about.

In addition to all of the regular ‘Government Day’ activities, the JDRF is hosting a blogger round table session, where we will be talking with, and taking questions from over 150 volunteers from across the country.  We are splitting into two groups to make discussion more feasible.

By chance, I got into the session that will be broadcast on the JDRF USTREAM channel.  Tune in on Sunday, March 13, at 2:15 PM EST to see the session.

There is a twitter ‘hashtag’, #JDRFGovDay, that will be used to round up tweets that happen throughout the event.  I’ll try to get some tweets sent too, but not at the expense of missing stuff happening right in front of me.  You can also keep an eye on the JDRF Advocacy Facebook page, which will have updates posted throughout the event.

To round things off, one of the best posts I’ve read about the upcoming event is from Scott Strange.  I think he did a great job of keeping all of this in perspective when he said:

This new outreach is still in its infancy and is a totally new mission for many chapters.  True mentoring programs were few and far between you might find a program to “mentor” people on how to help with fund-raising but not find one on how to help to cope with the day-to-day of diabetes.  Previously, Adult T1’s were viewed as either a volunteer, a donor, or a fund-raiser.

Like many things in life, this is about a new relationship, and it’s a new relationship that has, for some people, a fair amount of old baggage to deal with.  Me?  I’m excited that they are interested in doing more, and I’m happy to help all parties involved in any way I can.

In addition to all of this new relationship stuff, I’ll be able to catch most of their normal ‘Government Day’ meetings and sessions.  As someone who has always been a bit intimidated by politics,  this will be good exposure for me.

I fly out early in the morning, and with any luck I’ll be somewhere overairplane flying Wisconsin or Illinois when this post is published.  I even have the pleasure of meeting the above mentioned Scott Strange for breakfast in Chicago, then sharing a flight with him to D.C.   I hope that he behaves himself once we’re on the plane – I don’t want to be the one blogging about how an air marshal put him in a submission hold at 20,000 feet in the air…

** Disclosure: The JDRF is paying for my travel, lodging, and a few meals.  The JDRF has not placed any restrictions (or expectations) on what I blog about, and they have no editorial control before or after the event.  While I’m honored to have been invited, I also want people to recognize that this sort of thing is expensive for me in terms of time, energy, opportunity cost, and some out of pocket money.   Travel is never completely free.